MDFit: automated molecular simulations workflow enables high throughput assessment of ligands-protein dynamics.

Journal: Journal of computer-aided molecular design
Published Date:

Abstract

Molecular dynamics (MD) simulation is a powerful tool for characterizing ligand-protein conformational dynamics and offers significant advantages over docking and other rigid structure-based computational methods. However, setting up, running, and analyzing MD simulations continues to be a multi-step process making it cumbersome to assess a library of ligands in a protein binding pocket using MD. We present an automated workflow that streamlines setting up, running, and analyzing Desmond MD simulations for protein-ligand complexes using machine learning (ML) models. The workflow takes a library of pre-docked ligands and a prepared protein structure as input, sets up and runs MD with each protein-ligand complex, and generates simulation fingerprints for each ligand. Simulation fingerprints (SimFP) capture protein-ligand compatibility, including stability of different ligand-pocket interactions and other useful metrics that enable easy rank-ordering of the ligand library for pocket optimization. SimFPs from a ligand library are used to build & deploy ML models that predict binding assay outcomes and automatically infer important interactions. Unlike relative free-energy methods that are constrained to assess ligands with high chemical similarity, ML models based on SimFPs can accommodate diverse ligand sets. We present two case studies on how SimFP helps delineate structure-activity relationship (SAR) trends and explain potency differences across matched-molecular pairs of (1) cyclic peptides targeting PD-L1 and (2) small molecule inhibitors targeting CDK9.

Authors

  • Alexander C Brueckner
    Molecular Structure & Design, Bristol Myers Squibb, Princeton, NJ, 08540, USA. bruecknera15@gmail.com.
  • Benjamin Shields
    Biomedical Technology Services, Townsville University Hospital, Townsville, Australia. benjamin.shields@health.qld.gov.au.
  • Palani Kirubakaran
    Biocon Bristol Myers Squibb R&D Centre, Bangalore, 560099, Karnataka, India.
  • Alexander Suponya
    Molecular Structure & Design, Bristol Myers Squibb, Princeton, NJ, 08540, USA.
  • Manoranjan Panda
    AstraZeneca India Pvt. Ltd. , Bangalore 560045, India.
  • Shana L Posy
    Molecular Structure & Design, Bristol Myers Squibb, Princeton, NJ, 08540, USA.
  • Stephen Johnson
    Molecular Structure & Design, Bristol Myers Squibb, Princeton, NJ, 08540, USA.
  • Sirish Kaushik Lakkaraju
    Molecular Structure & Design, Bristol Myers Squibb, Princeton, NJ, 08540, USA. kaushik.lakkaraju@bms.com.